3. Narain R (ed) (2011) Engineered carbohydrate-based materials for biomedical applicationsPolymers, surfaces, dendrimers, nanoparticles, and hydrogels. Wiley, Hoboken
4. Marradi M, Garcia I, Penade ´s S (2011) Carbohydrate-based nanoparticles for potential
applications in medicine. Prog Mol Biol Transl Sci 104:141–173
5. Garcia I, Gallo J, Marradi M et al (2011) Glyconanoparticles: new nanomaterials for
biological applications. In: Narain R (ed) Engineered carbohydrate-based materials for
biomedical applications-polymers, surfaces, dendrimers, nanoparticles, and hydrogels.
Wiley, Hoboken
6. El-Boubbou HX, Huang X (2011) Glyco-nanomaterials: translating insights from the “sugar
code” to biomedical applications. Curr Med Chem 18:2060–2078
7. Garcia I, Marradi M, Penade ´s S (2010) Glyconanoparticles: multifunctional nanomaterials
for biomedical applications. Nanomedicine 5:777–792
8. De la Fuente JM, Penade ´s S (2006) Glyconanoparticles: types, synthesis and applications in
glycoscience, biomedicine and material science. Biochim Biophys Acta 1760:636–651
9. Cipolla L, Peri F, Airoldi C (2008) Glycoconjugates in cancer therapy. Anticancer Agents
Med Chem 8:92–121
10. Newkome GR, Moorefield CN, Vo ¨gtle F (2001) Dendrimers and dendrons: concepts, synthesis,
applications. Wiley, New York
11. Fre ´chet JMJ, Tomalia D (2001) Dendrimers and other dendritic polymers. Wiley, New York
12. Buhleier E, Wehner W, Vo ¨gtle F (1978) “Cascade”- and “Nonskid-Chain-like” syntheses of
molecular cavity topologies. Synthesis 1978:155–158
13. Newkome GR, Z-q Y, Baker GR et al (1985) Micelles. Part 1. Cascade molecules: a new
approach to micelles. A [27]-arborol. J Org Chem 50:2004–2006
14. Tomalia DA, Baker H, Dewald J et al (1985) A new class of polymers: starburst-dendritic
macromolecules. Polym J 17:117–132
15. Haag R, Kratz F (2006) Polymer therapeutics: concepts and applications. Angew Chem Int
Ed Engl 45:1198–1215
16. Tekade RK, Kumar PV, Jain NK (2009) Dendrimers in oncology: an expanding horizon.
Chem Rev 109:49–87
17. Duncan R, Izzo L (2005) Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev 57:
2215–2237
18. Boas U, Christensen JB, Heegaard PMH (2006) Dendrimers in medicine and biotechnology:
new molecular tools. RSC Publishing, Cambridge
19. Roy R, Zanini D, Meunier SJ et al (1993) Solid phase synthesis of dendritic sialoside
inhibitors of influenza A virus haemagglutinin. J Chem Soc Chem Commun 1993:1869–1872
20. Lundquist JL, Toone EJ (2002) The cluster glycoside effect. Chem Rev 102:555–578
21. Roy R (1996) Syntheses and some applications of chemically defined multivalent
glycoconjugates. Curr Opin Struct Biol 6:692–702
22. Chabre YM, Roy R (2010) Design and creativity in synthesis of multivalent neoglycoconjugates. Adv Cabohydr Chem Biochem 63:165–393
23. Chabre YM, Roy R (2008) Recent trends in glycodendrimer syntheses and applications.
Curr Top Med Chem 8:1237–1285
24. Roy R (2003) A decade of glycodendrimer chemistry. Trends Glycosci Glycotechnol
15: 291–310
25. Touaibia M, Roy R (2007) Glycodendrimers as anti-adhesin drugs against type 1 fimbriated
E. coli uropathogenic infections. Mini Rev Med Chem 7:1270–1283
26. Nepogodiev SA, Stoddart JF (2003) Glycodendrimers: chemical aspects. Adv Macromol
Carbohydr Res 2:191–239
27. Ro ¨ckendorf N, Lindhorst TK (2001) Glycodendrimers. Top Curr Chem 217:201–238
28. Cloninger MJ (2002) Biological applications of dendrimers. Curr Opin Chem Biol 6:42–748
29. Bezouska K (2002) Design, functional evaluation and biomedical applications of carbohydrate dendrimers (glycodendrimers). Rev Mol Biotechnol 90:269–290
336
N. Kottari et al.
Précédent

- 340/349

Suivant